A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
Idorsia
Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
21/04/2020 - 3 minutes
Top Cardiology Biotech News from the ESC Conference 2019
Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest…
05/09/2019 - 4 minutes
The Top 20 Women in Leading Biotech Roles in Europe
The biotech industry has often been criticized for its lack of gender diversity. While there…
21/05/2019 - 12 minutes
The Billion-Euro European Biotech Companies in 2018
Here’s the list of the European biotech companies, both public and private, that are worth…
29/10/2018 - 7 minutes
Swiss Biotech Tackles Brain Artery Constriction Caused by Hemorrhage
Idorsia will start a Phase III trial to study the efficacy of its drug in…
18/06/2018 - 2 minutes
Actelion’s Billion-Euro Spin-Off Starts First Phase III Trial in its Pipeline
Idorsia has started the first Phase III study in its pipeline to test the drug…
16/05/2018 - 3 minutes
Say Hello to the Top 14 Entrepreneurial Women in European Biotech
Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting…
08/03/2018 - 8 minutes
How is Actelion Spin-Off Idorsia Doing One Year Later?
Actelion's spin-off Idorsia was blessed with a large pipeline and a healthy bank balance. How…
01/03/2018 - 3 minutes
Happy 2018, Here Are the Top 9 European Biotech Companies To Watch
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
09/01/2018 - 5 minutes
Actelion Spin Out and Roche Join Forces to Develop Cancer Immunotherapies
Idorsia and Roche have agreed on a research collaboration, with the big pharma getting exclusive…
20/12/2017 - 2 minutes
Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III
Idorsia will collaborate with Janssen on the development of its hypertension drug, aprocitentan, which could…
04/12/2017 - 3 minutes
